Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dose-response aggregometry in maternal/neonatal platelets.

A M Gader1, H Bahakim, F A Jabbar

  • 1Department of Physiology, College of Medicine & King Khaled University Hospital, Riyadh, Saudi Arabia.

Thrombosis and Haemostasis
|October 31, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet Aggregometry - Dose-related Responses to Arachidonic Acid in Childhood Nephrotic Syndrome.

Platelets·2010
Same author

Dipyridamole in the Management of Severe Heparin-associated Thrombocytopenia.

Platelets·2010
Same author

Heat stroke and platelets.

Platelets·2010
Same author

Ethnic variations in platelet aggregation-comparison between saudi arabs, westerners (europeans and americans), asians and africans.

Platelets·2010
Same author

A Study of the Normal Pattern of Platelet Aggregation in Healthy Saudis: A Population-based Study.

Platelets·2010
Same author

Moyamoya syndrome with unusual angiographic findings and protein C deficiency: review of the literature.

Journal of the neurological sciences·1998
Same journal

Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

Thrombosis and haemostasis·2026
Same journal

The Interaction of Fibrin with Endothelial Cell Receptor N-Cadherin Promotes Fibrin-Dependent Angiogenesis.

Thrombosis and haemostasis·2026
Same journal

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Thrombosis and haemostasis·2026
Same journal

Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

Thrombosis and haemostasis·2026
Same journal

Methylglyoxal Promotes RBC-Driven Procoagulant Activity and Venous Thrombosis under Diabetes-Relevant Conditions.

Thrombosis and haemostasis·2026
Same journal

Management of Inferior Vena Cava Thrombosis: Guidance from the Italian Society for the Study of Haemostasis and Thrombosis.

Thrombosis and haemostasis·2026
See all related articles

Neonatal platelets show enhanced aggregation responses to common agonists compared to maternal platelets, challenging previous findings of impaired neonatal platelet function. This study analyzed platelet aggregation in maternal/neonatal pairs and controls.

Area of Science:

  • Hematology
  • Neonatal Physiology
  • Platelet Biology

Background:

  • Platelet aggregation is crucial for hemostasis.
  • Previous studies suggested impaired neonatal platelet function.
  • Understanding maternal and neonatal platelet responses is vital for perinatal health.

Purpose of the Study:

  • To investigate and compare platelet aggregation responses between maternal and neonatal pairs.
  • To analyze the effects of various agonists (ADP, collagen, arachidonic acid, ristocetin) on platelet aggregation.
  • To reconcile conflicting data on neonatal platelet aggregation.

Main Methods:

  • Collected platelet samples from 240 maternal/neonatal pairs at childbirth.
  • Compared responses to healthy nonpregnant adult controls.

Related Experiment Videos

  • Measured lag phase, slope, and maximum aggregation (MA%) to different agonist doses.

    • Main Results:

    • Neonatal and adult platelets showed enhanced responses to decreasing doses of ADP, arachidonic acid, and ristocetin compared to maternal platelets.
    • Enhanced responses were more consistent in aggregation curve slopes than in MA%.
    • Neonatal platelets exhibited a faster aggregation rate with collagen than maternal platelets, despite a longer lag phase, with no difference in MA%.

    Conclusions:

    • Neonatal platelet aggregation responses are not consistently impaired and can be enhanced compared to maternal platelets.
    • Findings contradict previous reports suggesting impaired neonatal platelet function.
    • Further research is needed to explore the reasons for these discrepancies and their clinical implications.